Abstract
Increased arterial stiffness is an important marker for target organ damage in essential hypertension. Both serum uric acid (UA) and C-reactive protein (CRP) were reported to be associated with target organ damage. However, the influences of UA and CRP on large arterial stiffness were not well elucidated. This study included 200 essential hypertension patients (64 women) whose age was between 20 and 50 years old (mean age 41 ± 8 years). None of the patients had diabetes mellitus or overt end-organ damage. Arterial stiffness was assessed by pulse-wave velocity (PWV) measured by tonometry from carotid to radial artery. Serum UA, high-sensitivity CRP (hsCRP), glucose, insulin, and lipid profiles were measured at the same time in each patient. PWV levels were significantly correlated with mean blood pressure (r = 0.245, P < 0.001), diastolic blood pressure (r = 0.323, P < 0.001), high-density lipoprotein (r = −0.169, P = 0.016), and UA (r = 0.234, P = 0.001), but not age, body mass index, blood sugar, insulin, low-density lipoprotein, triglyceride, and hsCRP. Pulsewave velocity levels were significantly higher in males (8.9 ± 1.2 vs 8.2 ± 1.2 m/s, P < 0.001) and smokers (9.3 ± 1.1 vs 8.5 ± 1.2 m/s, P < 0.001). Uric acid was significantly correlated with hsCRP (r = 0.294, P < 0.001). After multivariate analysis controlling for all possible confounding factors, UA (odds ratio 1.28, 95% confidence interval 1.02–1.61, P = 0.032) was still independently associated with increased PWV. In conclusion, UA but not hsCRP was independently associated with increased PWV in essential hypertension. Although UA was correlated with hsCRP, the association between UA and PWV was not through the effect of enhanced inflammation.
Similar content being viewed by others
References
Baker JF, Krishnan E, Chen L, Schumacher HR (2005) Serum uric acid and cardiovascular disease: Recent developments and where do they leave us? Am J Med 118:816–826
Ebrahimpour P, Fakhrzadeh H, Heshmat R, Bandarian F, Larijani B (2008) Serum uric acid levels and risk of metabolic syndrome in healthy adults. Endocr Pract 14:298–304
Niskanen LK, Laaksonen DE, Nyyssonen K, Alfthan G, Lakka HM, Lakka TA, Salonen JT (2004) Uric acid level as a risk factor for cardiovascular and all-cause mortality in middle-aged men: a prospective cohort study. Arch Intern Med 164:1546–1551
Short RA, Johnson RJ, Tuttle KR (2005) Uric acid, microalbuminuria and cardiovascular events in high-risk patients. Am J Nephrol 25:36–44
Verdecchia P, Schillaci G, Reboldi G, Santeusanio F, Porcellati C, Brunetti P (2000) Relation between serum uric acid and risk of cardiovascular disease in essential hypertension: the PIUMA study. Hypertension 36:1072–1078
Viazzi F, Parodi D, Leoncini G, Parodi A, Falqui V, Ratto E, Vettoretti S, Bezante GP, Del Sette M, Deferrari G, Pontremoli R (2005) Serum uric acid and target organ damage in primary hypertension. Hypertension 45:991–996
Campo C, Ruilope LM, Segura J, Rodicio JL, Garcia-Robles R, Garcia-Puig J (2003) Hyperuricemia, low urine urate excretion and target organ damage in arterial hypertension. Blood Pressure 12:277–283
Leoncini G, Ratto E, Viazzi F, Vaccaro V, Parodi A, Falqui V, Conti N, Tomolillo C, Deferrari G, Pontremoli R (2007) Metabolic syndrome and ambulatory arterial stiffness index in non-diabetic patients with primary hypertension. J Hum Hypertens 21:802–807
Wykretowicz A, Metzler L, Milewska A, Balinski M, Rutkowska A, Adamska K, Krauze T, Guzik P, Dziarmaga M, Wysocki H (2008) Noninvasively assessed pulsatility of ascending aortic pressure waveform is associated with the presence of coronary artery narrowing. Heart Vessels 23:16–19
Chen JY, Tsai WC, Lin CC, Huang YY, Hsu CH, Liu PY, Lin LJ, Chen JH (2005) Stiffness index derived from digital volume pulse as a marker of target organ damage in untreated hypertension. Blood Pressure 14:233–237
Bassuk SS, Rifai N, Ridker PM (2004) High-sensitive C-reactive protein. Curr Probl Cardiol 29:439–493
Bautista LE, Atwood JE, O’Malley PG, Taylor AJ (2004) Association between C-reactive protein and hypertension in healthy middle-aged men and women. Coron Artery Dis 15:331–336
Conen D, Zeller A, Pfisterer M, Martina B (2006) Usefulness of B-type natriuretic peptide and C-reactive protein in predicting of the presence or absence of left ventricular hypertrophy in patients with systemic hypertension. Am J Cardiol 97:249–252
Tsai WC, Lin CC, Huang YY, Chen JY, Chen JH (2007) Association of increased arterial stiffness and inflammation with protein uria and left ventricular hypertrophy in non-diabetic hypertensive patients. Blood Pressure 16:270–275
Yasmin, McEniery CM, Wallace S, Mackenzie IS, Cockcroft JR, Wilkinson IB (2004) C-reactive protein is associated with arterial stiffness in apparently healthy individuals. Arterioscler Thromb Vasc Biol 24:969–974
Johnson RJ, Kang DH, Feig D, Kivlighn S, Kanellis J, Watanabe S, Tuttle KR, Rodriguez-Iturbe B, Herrera-Acosta J, Mazzali M (2003) Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease? Hypertension 41:1183–1190
Saijo Y, Utsugi M, Yoshioka E, Horikawa N, Sato T, Gong YY, Kishi R (2005) Relationships of C-reactive protein, uric acid, and glomerular filtration rate to arterial stiffness in Japanese subjects. J Hum Hypertens 19:907–913
Tsai WC, Chen JY, Wang MC, Wu HT, Chi CK, Chen YK, Chen JH, Lin LJ (2005) Association of risk factors with increased pulse wave velocity detected by a novel method using dual-channel photoplethysmography. Am J Hypertens 18:1118–1122
Tsai WC, Li YH, Lin CC, Chao TH, Chen JH (2004) Effects of oxidative stress on endothelial function after a high-fat meal. Clin Sci 106:315–319
Erdogan D, Gullu H, Caliskan M, Yildirim E, Bilgi M, Ulus T, Sezgin N, Muderrisoglu H (2005) Relationship of serum uric to measures of endothelial function and atherosclerosis in healthy adults. Int J Clin Pract 59:1276–1282
Kato M, Hisatome I, Tomikura Y, Kotani K, Kinugawa T, Ogino K, Ishida K, Igawa O, Shigemasa C, Somers VK (2005) Status of endothelial vasodilation in patients with hyperuricemia. Am J Cardiol 96:1576–1578
Mercuro G, Vitale C, Cerquetani E, Zoncu S, Deidda M, Fini M, Rosane GMC (2004) Effect of hyperuricemia upon endothelial function in patients at increased cardiovascular risk. Am J Cardiol 94:932–935
Tsai WC, Li YH, Huang YY, Lin CC, Chao TH, Chen JH (2005) Plasma vascular endothelial growth factor as a marker for early vascular damage in hypertension. Clin Sci 109:39–43
Kampus P, Kals J, Ristimac T, Fischer K, Zilmer M, Teesalu R (2004) High-sensitivity C-reactive protein affects central hemodynamics and augmentation index in apparently healthy persons. J Hypertens 24:969–974
Andoh N, Minami J, Ishimitsu T, Ohrui M, Matsuoka H (2006) Relationship between markers of inflammation and brachial-ankle pulse wave velocity in Japanese men. Int Heart J 47:409–420
Schwedler SB, Filep JG, Galle J, Wanner C, Potempa LA (2006) C-reactive protein: a family of proteins to regulate cardiovascular function. Am J Kidney Dis 47:212–222
Mizia-Stec K, Gasior Z, Zahorska-Markiewicz B, Holecki M, Haberka M, Gomulka S, Zak-Golab A, Goscinska A (2008) The indexes of arterial structure and function in women with simple obesity: a preliminary study. Heart Vessels 23:224–229
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Tsai, WC., Huang, YY., Lin, CC. et al. Uric acid is an independent predictor of arterial stiffness in hypertensive patients. Heart Vessels 24, 371–375 (2009). https://doi.org/10.1007/s00380-008-1127-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00380-008-1127-9